Theriva Biologics, Inc. (TOVX) has disclosed a new risk, in the Capital Markets category.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Theriva Biologics, Inc. faces significant business risks due to potential changes in trade policy, including tariffs and customs regulations. These changes could arise from shifts in U.S. or international political, regulatory, and economic conditions, affecting the company’s operations and financial health. The imposition of tariffs, particularly in key markets like China, where they have engaged vendors, could lead to retaliatory measures, impacting their business and reputation. Additionally, protectionist trends could further complicate the trade environment, posing a material threat to their financial condition and operational results.
The average TOVX stock price target is $7.00, implying 1,554.85% upside potential.
To learn more about Theriva Biologics, Inc.’s risk factors, click here.